AstraZeneca, Pregliasco: “New anguish not infectious vaccination campaign”

After the death of Camilla, the 18-year-old Ligurian who had the AstraZeneca vaccine on May 25 during an Open Day, the Vaxzevria serum returns to the spotlight. “A second moment of anguish” that Fabrizio Pregliasco hopes “will not affect the vaccination campaign as a whole”. “I consider it very important and necessary to have a comprehensive vaccination” against Covid-19, “also for young people. For them at this point, also to guarantee and reassure their parents and especially the children” themselves, “who have shown a great desire to vaccinate, it will be important to “use” in a preferential way the vaccines that have a higher safety profile “in the young age groups,” therefore the mRna vaccines “, said the virologist of the State University of Milan, speaking at ‘Agorà’ on Rai3. “I hope that this second moment of anguish on AstraZeneca does not affect the vaccination campaign as a whole – hopes the expert – because the virus is circulating and as we see in Gb, but also in other countries, it hits its tail. Only thanks to vaccination. we will be able to avoid in the future the proportion of serious cases that has been highlighted in the epidemic waves experienced so far, warns Pregliasco, reiterating the effectiveness and safety of anti-Covid vaccines. The case of the young woman from Sestri Levante, although of course “an investigation will be necessary” to prove it, “in fact today becomes the fifth death potentially attributable in a slightly more structured way to Covid-19 vaccines – recalls Pregliasco – of which one with mRna vaccine and 4 with AstraZeneca “, out of tens of millions of administrations. The virologist expresses “great pain” for the loss of a new human life, but understands the reasons why he pressed on the accelerator of the vaccination campaign: “In statistical terms – he highlights – it is estimated that vaccinations and the speed with which have been implemented have saved at least 10 thousand human lives “. As for the possibility, for those who have already received a first dose of Vaxzevria, to take the second, the expert reassures: “I receive distressed messages, but to date no cases of thrombosis have been registered after the second dose of AstraZeneca. Current indications they say it can be done “, even if” it is likely that in the future the possibility of a mix “between different first and second dose vaccines will be defined.